It is currently challenging to adequately model the growth and migration of glioblastoma using two-dimensional (2D) in vitro culture systems as they quickly lose the original, patient-specific identity and heterogeneity. However, with the advent of three-dimensional (3D) cell cultures and human-induced pluripotent stem cell (iPSC)-derived cerebral organoids (COs), studies demonstrate that the glioblastoma-CO (GLICO) coculture model helps to preserve the phenotype of the patient-specific tissue. Here, we aimed to set up such a model using mature COs and develop a pipeline for subsequent analysis of cocultured glioblastoma. Our data demonstrate that the growth and migration of the glioblastoma cell line within the mature COs are significantly increased in the presence of extracellular matrix proteins, shortening the time needed for glioblastoma to initiate migration. We also describe in detail the method for the visualization and quantification of these migrating cells within the GLICO model. Lastly, we show that this coculture model (and the human brain-like microenvironment) can significantly transform the gene expression profile of the established U87 glioblastoma cell line into proneural and classical glioblastoma cell types.

Department of Genome Integrity Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

Department of Histology and Embryology Faculty of Medicine Masaryk University Brno Czech Republic

International Clinical Research Center St Anne's University Hospital Brno Czech Republic

Laboratory of Gene Expression Institute of Biotechnology CAS BIOCEV Vestec Czech Republic

Zobrazit více v PubMed

Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 2014;16(Suppl 4):iv1–63. PubMed PMC

Stupp R, Hegi ME, Mason WP, van den Bent M, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5‐year analysis of the EORTC‐NCIC trial. Lancet Oncol. 2009;10:459–66. PubMed

Poon MTC, Sudlow CLM, Figueroa JD, Brennan PM. Longer‐term (≥ 2 years) survival in patients with glioblastoma in population‐based studies pre‐ and post‐2005: a systematic review and meta‐analysis. Sci Rep. 2020;10:11622. PubMed PMC

Lancaster MA, Renner M, Martin C‐A, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501:373–9. PubMed PMC

Bian S, Repic M, Guo Z, Kavirayani A, Burkard T, Bagley JA, et al. Genetically engineered cerebral organoids model brain tumour formation. Nat Methods. 2018;15:631–9. PubMed PMC

Ogawa J, Pao GM, Shokhirev MN, Verma IM. Glioblastoma model using human cerebral organoids. Cell Rep. 2018;23:1220–9. PubMed PMC

Bhaduri A, Di Lullo E, Jung D, Müller S, Crouch EE, Espinosa CS, et al. Outer radial glia‐like cancer stem cells contribute to heterogeneity of glioblastoma. Cell Stem Cell. 2020;26:48–63.e6. PubMed PMC

da Silva B, Mathew RK, Polson ES, Williams J, Wurdak H. Spontaneous glioblastoma spheroid infiltration of early‐stage cerebral organoids models brain tumor invasion. SLAS Discov. 2018;23:862–8. PubMed

Goranci‐Buzhala G, Mariappan A, Gabriel E, Ramani A, Ricci‐Vitiani L, Buccarelli M, et al. Rapid and efficient invasion assay of glioblastoma in human brain organoids. Cell Rep. 2020;31:107738. PubMed

Krieger TG, Tirier SM, Park J, Jechow K, Eisemann T, Peterziel H, et al. Modeling glioblastoma invasion using human brain organoids and single‐cell transcriptomics. Neuro Oncol. 2020;22:1138–49. PubMed PMC

Linkous A, Balamatsias D, Snuderl M, Edwards L, Miyaguchi K, Milner T, et al. Modeling patient‐derived glioblastoma with cerebral organoids. Cell Rep. 2019;26:3203–11.e5. PubMed PMC

Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, et al. Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas. Cancer Discov. 2020;10:964–79. PubMed PMC

Mariappan A, Goranci‐Buzhala G, Ricci‐Vitiani L, Pallini R, Gopalakrishnan J. Trends and challenges in modeling glioma using 3D human brain organoids. Cell Death Differ. 2021;28:15–23. PubMed PMC

Raska J, Hribkova H, Klimova H, Fedorova V, Barak M, Barta T, et al. Generation of six human iPSC lines from patients with a familial Alzheimer's disease (n = 3) and sex‐ and age‐matched healthy controls (n = 3). Stem Cell Res. 2021;53:102379. PubMed

Raska J, Klimova H, Sheardova K, Fedorova V, Hribkova H, Pospisilova V, et al. Generation of three human iPSC lines from patients with a spontaneous late‐onset Alzheimer's disease and three sex‐ and age‐matched healthy controls. Stem Cell Res. 2021;53:102378. PubMed

Camp JG, Badsha F, Florio M, Kanton S, Gerber T, Wilsch‐Bräuninger M, et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci USA. 2015;112:15672–7. PubMed PMC

Lancaster MA, Knoblich JA. Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc. 2014;9:2329–40. PubMed PMC

Besse A, Sana J, Lakomy R, Kren L, Fadrus P, Smrcka M, et al. MiR‐338‐5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumor Biol. 2016;37:7719–27. PubMed

Ondracek J, Fadrus P, Sana J, Besse A, Loja T, Vecera M, et al. Global MicroRNA expression profiling identifies unique MicroRNA pattern of radioresistant glioblastoma cells. Anticancer Res. 2017;37:1099–104. PubMed

Fedorova V, Vanova T, Elrefae L, Pospisil J, Petrasova M, Kolajova V, et al. Differentiation of neural rosettes from human pluripotent stem cells in vitro is sequentially regulated on a molecular level and accomplished by the mechanism reminiscent of secondary neurulation. Stem Cell Res. 2019;40:101563. PubMed

Susaki EA, Tainaka K, Perrin D, Yukinaga H, Kuno A, Ueda HR. Advanced CUBIC protocols for whole‐brain and whole‐body clearing and imaging. Nat Protoc. 2015;10:1709–27. PubMed

Wingett SW, Andrews S. FastQ screen: a tool for multi‐genome mapping and quality control. F1000Res. 2018;7:1338. PubMed PMC

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA‐seq aligner. Bioinformatics. 2013;29:15–21. PubMed PMC

Kopylova E, Noé L, Touzet H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics. 2012;28:3211–7. PubMed

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA‐seq data with DESeq2. Genome Biol. 2014;15:550. PubMed PMC

org.Hs.eg.db . Bioconductor. Available at http://bioconductor.org/packages/org.Hs.eg.db/. Accessed 14 April 2022.

Blighe K. EnhancedVolcano: publication‐ready volcano plots with enhanced colouring and labeling. 2022.

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. PubMed PMC

Yu G, Wang L‐G, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7. PubMed PMC

Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98–110. PubMed PMC

Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, Lee H, et al. U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet. 2010;6:e1000832. PubMed PMC

Bohaciakova D, Hruska‐Plochan M, Tsunemoto R, Gifford WD, Driscoll SP, Glenn TD, et al. A scalable solution for isolating human multipotent clinical‐grade neural stem cells from ES precursors. Stem Cell Res Ther. 2019;10:83. PubMed PMC

Marques‐Torrejon MA, Gangoso E, Pollard SM. Modelling glioblastoma tumour‐host cell interactions using adult brain organotypic slice co‐culture. Dis Model Mech. 2018;11:dmm031435. PubMed PMC

Dityatev A, Schachner M, Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci. 2010;11:735–46. PubMed

Song I, Dityatev A. Crosstalk between glia, extracellular matrix and neurons. Brain Res Bull. 2018;136:101–8. PubMed

Lam D, Enright HA, Cadena J, Peters SKG, Sales AP, Osburn JJ, et al. Tissue‐specific extracellular matrix accelerates the formation of neural networks and communities in a neuron‐glia co‐culture on a multi‐electrode array. Sci Rep. 2019;9:4159. PubMed PMC

Aisenbrey EA, Murphy WL. Synthetic alternatives to Matrigel. Nat Rev Mater. 2020;5:539–51. PubMed PMC

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. Tumor evolution of glioma‐intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2017;32:42–56.e6. PubMed PMC

Allen M, Bjerke M, Edlund H, Nelander S, Westermark B. Origin of the U87MG glioma cell line: good news and bad news. Sci Transl Med. 2016;8:354re3. PubMed

Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate